Journal of Immunology Research

Inflammation in Cancer: Part of the Problem or Part of the Solution? 2020


Publishing date
01 Nov 2020
Status
Closed
Submission deadline
03 Jul 2020

Lead Editor

1Victor Babes National Institute of Pathology Institute, Romania

2University of Pittsburgh, USA

3University of Verona, Italy

This issue is now closed for submissions.

Inflammation in Cancer: Part of the Problem or Part of the Solution? 2020

This issue is now closed for submissions.

Description

Following the growing interest on complex inflammatory processes, intense research is going on to establish its role in human diseases. The immune system triggers an array of inflammatory reactions as a response to any exogenous and/or endogenous homeostasis disturbing factors. These processes are vital to preserve cells, tissues, and organ integrity, but since they comprise complex elements, regulation of this array of events is the main key for maintaining a normal physiological, efficient process. Regulatory mechanisms, some of them still unknown, are needed to balance the immune response. Thus, an insufficient response may cause immunodeficiency resulting in infection, cancer, neurodegeneration and various other human diseases.

The aim of this Special Issue is to collate original research and review articles that tackle chronic inflammation triggering/favoring oncogenesis of solid tumors, as well as those reporting the inflammation process as a mechanism for efficient immune therapy in oncology. We invite investigators to contribute with reviews and original papers describing recent findings in oncology field with focus on inflammation as part of the problem or part of the solution in tumor process/disease evolution.

Potential topics include but are not limited to the following:

  • Proteomics/immunoproteomics biomarkers for monitoring inflammation in skin cancer, brain cancer, and other types of tumors
  • The innate-adaptive immune systems interface in inflammation
  • Signaling inflammation-mediated events as tumorigenesis triggers
  • Inflammasomes in cancer
  • Inflammation and transcriptomics
  • Epigenetics of inflammation
  • New methodological approaches for inflammation evaluation in cancer
  • New avenues of immune therapy in cancer
  • Personalized medicine through inflammatory status evaluation
  • Bioinformatics: main tool for human inflammasome approaches
  • Inflammaging as tumorigenesis trigger
  • Environmental triggers of inflammation leading to oncogenesis
Journal of Immunology Research
 Journal metrics
See full report
Acceptance rate11%
Submission to final decision121 days
Acceptance to publication27 days
CiteScore6.000
Journal Citation Indicator0.560
Impact Factor4.1
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.